These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 27164323)

  • 21. Perspectives on vaccines against varicella-zoster virus infections.
    Gershon AA; Gershon MD
    Curr Top Microbiol Immunol; 2010; 342():359-72. PubMed ID: 20232192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.
    Holcomb K; Weinberg JM
    J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying optimal vaccination scenarios to reduce varicella zoster virus transmission and reactivation.
    Bakker KM; Eisenberg MC; Woods RJ; Martinez ME
    BMC Med; 2022 Oct; 20(1):387. PubMed ID: 36209074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding the immunology of the Zostavax shingles vaccine.
    Sullivan NL; Eberhardt CS; Wieland A; Vora KA; Pulendran B; Ahmed R
    Curr Opin Immunol; 2019 Aug; 59():25-30. PubMed ID: 30970291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Varicella-zoster virus: overview and clinical manifestations.
    Arvin AM
    Semin Dermatol; 1996 Jun; 15(2 Suppl 1):4-7. PubMed ID: 8840410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination to prevent varicella: Goldman and King's response to Myers' interpretation of Varicella Active Surveillance Project data.
    Goldman GS; King PG
    Hum Exp Toxicol; 2014 Aug; 33(8):886-93. PubMed ID: 24275643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Reactivation of herpes zoster infection by varicella-zoster virus].
    Cvjetković D; Jovanović J; Hrnjaković-Cvjetković I; Brkić S; Bogdanović M
    Med Pregl; 1999; 52(3-5):125-8. PubMed ID: 10518396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune responses to varicella-zoster virus.
    Arvin AM
    Infect Dis Clin North Am; 1996 Sep; 10(3):529-70. PubMed ID: 8856351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular and therapeutic aspects of varicella-zoster virus infection.
    Quinlivan M; Breuer J
    Expert Rev Mol Med; 2005 Aug; 7(15):1-24. PubMed ID: 16098235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Varicella-zoster virus vaccine--grown-ups need it, too.
    Gilden DH
    N Engl J Med; 2005 Jun; 352(22):2344-6. PubMed ID: 15930426
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical and molecular pathogenesis of varicella virus infection.
    Gilden DH; Cohrs RJ; Mahalingam R
    Viral Immunol; 2003; 16(3):243-58. PubMed ID: 14583142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009.
    Weinmann S; Chun C; Schmid DS; Roberts M; Vandermeer M; Riedlinger K; Bialek SR; Marin M
    J Infect Dis; 2013 Dec; 208(11):1859-68. PubMed ID: 23922376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.
    Breuer J; Whitley R
    Herpes; 2007 Sep; 14 Suppl 2():25-9. PubMed ID: 17939892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of herpes zoster and its painful and debilitating complications.
    Johnson R; McElhaney J; Pedalino B; Levin M
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S43-8. PubMed ID: 18162246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
    Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
    Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in the treatment of varicella-zoster virus infections.
    Andrei G; Snoeck R
    Adv Pharmacol; 2013; 67():107-68. PubMed ID: 23886000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ORF61 Protein Encoded by Simian Varicella Virus and Varicella-Zoster Virus Inhibits NF-κB Signaling by Interfering with IκBα Degradation.
    Whitmer T; Malouli D; Uebelhoer LS; DeFilippis VR; Früh K; Verweij MC
    J Virol; 2015 Sep; 89(17):8687-700. PubMed ID: 26085158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The current status of live attenuated varicella vaccine.
    Gershon AA
    Arch Virol Suppl; 2001; (17):1-6. PubMed ID: 11339539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular studies of Varicella zoster virus.
    Quinlivan M; Breuer J
    Rev Med Virol; 2006; 16(4):225-50. PubMed ID: 16791838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses.
    Weinberg A; Lazar AA; Zerbe GO; Hayward AR; Chan IS; Vessey R; Silber JL; MacGregor RR; Chan K; Gershon AA; Levin MJ
    J Infect Dis; 2010 Apr; 201(7):1024-30. PubMed ID: 20170376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.